London
7 °C
Manchester
Glasgow
Dublin
Belfast
Washington
-5 °C
Denver
6 °C
Atlanta
Dallas
Houston Texas
New Orleans
El Paso
9 °C
Phoenix
Los Angeles
-5 °C
14 °C
19 °C
29 °C
21 °C
31 °C
Featured
Last news
NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close
SHELTON, CONNECTICUT / ACCESS Newswire / November 12, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced the closing of its previously announced securities purchase agreement with a single healthcare institutional investor for the purchase and sale of 3,571,429 shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $1.68 per share in a registered direct offering (the "Offering"). The gross proceeds from the Offering are approximately $6 million, before deducting placement agent commissions and other offering expenses. In addition, in a concurrent private placement, the Company has issued and sold Series A warrants to purchase up to 3,571,429 shares of common stock (the "Series A Warrants") and Series B warrants to purchase up to 3,571,429 shares of common stock (the "Series B Warrants" and, together with the Series A Warrants, the "Warrants"). The Series A Warrants have an exercise price of $1.75 per share, are exercisable after 6 months from date of issuance, and expire 2 years following the issuance date. The Series B Warrants have an exercise price of $2.00 per share, are exercisable after 6 months from date of issuance, and expire 5.5 years following the issuance date. The exercise price of the Series B Warrants represents approximately a 20% premium to the closing price for the Company's common stock on November 10, 2025.
iTolerance CEO, Anthony Japour, Receives BioFlorida's Research & Developer of the Year Award
MIAMI, FL / ACCESS Newswire / November 12, 2025 / iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage privately-held biotechnology company focused on the development of innovative regenerative medicines, today announced that Anthony Japour, Chief Executive Officer and President of iTolerance, received the Research & Developer of the Year Award at the recently held BioFlorida Innovation Conference in Miami, FL.
Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line
New live-cell imaging data show that Telomir-1 markedly lowers intracellular iron levels at submicromolar concentrations in human keratinocytes, demonstrating potent cell penetration and iron-modulating activity - key to its broader epigenetic mechanism of action.
Dalet Named a Major Player in the 2025 IDC MarketScape for Worldwide Media Production, Distribution, and Monetization Integrated Cloud Solutions
NEW YORK, US / ACCESS Newswire / November 12, 2025 / Dalet, a leading provider of cloud-native, end-to-end media workflow solutions, today announced that it has been recognized as a Major Player in the IDC MarketScape: Worldwide Media Production, Distribution, and Monetization Integrated Cloud Solutions 2025 Vendor Assessment*. The report evaluates technology vendors helping media organizations streamline production, distribution, and monetization through unified cloud platforms.
Wellgistics Health Launches EinsteinRx as the Premier AI Prescription Management Hub Solution to Integrate Physical and Technology Healthcare Infrastructure
Consolidates messaging around Einstein Rx AI, Wellgistics Hub (formerly DelivMeds) and HubRx AI integration with pharmacies (in-house pharmacy and 6,500+ independent pharmacy network), physicians and manufacturersIntegration of technology and physical infrastructure positions Wellgistics with the "Pharmacy IT Railroad" to execute on PharmacyChain™ smart contracts for optimized healthcare delivery in the $634 billion United States prescription drug market
Arrival of US aircraft carrier fuels Venezuelan fears of attack
A US aircraft carrier strike group arrived in Latin America Tuesday, escalating a military buildup Venezuela has warned could trigger a full-blown conflict as it announced its own "massive" deployment.
Turkey seeks more than 2,000 years behind bars for Erdogan rival
Turkish prosecutors on Tuesday charged Istanbul's jailed mayor Ekrem Imamoglu with 142 offences in a massive legal case that could carry a penalty of more than 2,000 years in jail, court documents showed.
Prosecutor files 142 charges against Istanbul mayor, a top Erdogan critic
Turkish prosecutors on Tuesday charged Istanbul's jailed mayor Ekrem Imamoglu with 142 offences that could carry a penalty of hundreds of years in prison, court documents showed.
Pakistani Taliban claim deadly suicide attack in Islamabad
The Pakistani Taliban claimed a suicide bombing that killed at least 12 people in Islamabad on Tuesday, a rare attack by the militant group on the country's capital.
Suicide bombing in Islamabad kills 12, wounds 27
A suicide bombing outside district court buildings in the Pakistani capital Islamabad killed at least 12 people and wounded 27 on Tuesday, the interior minister said.
Indian PM calls deadly Delhi blast 'conspiracy'
Indian Prime Minister Narendra Modi on Tuesday called a deadly car explosion in the heart of the capital that killed at least eight people a "conspiracy", vowing those responsible will face justice.
India probes deadly Delhi blast, vows those responsible will face justice
India's defence minister vowed on Tuesday that those responsible for a deadly car explosion in the heart of the capital that killed at least eight people will face justice.
Philippines digs out from Typhoon Fung-wong as death toll climbs to 18
Rescuers using backhoes and chainsaws began digging the Philippines out from the devastation of Typhoon Fung-wong on Tuesday, as floodwaters receded in hundreds of villages and the storm's death toll climbed to 18.
Sony hikes profit forecasts on strong gaming, anime sales
Japanese giant Sony hiked its full-year revenue and profit forecasts Tuesday on the back of the huge global success of the latest "Demon Slayer" anime blockbuster.
Indian forensic teams scour deadly Delhi car explosion
Indian crime scene investigators scoured through the wreckage of a car on Tuesday that exploded hours earlier in the heart of the capital, killing at least eight people.
Climate Goals Threatened by Industrialised Animal Farming, Reveals Key International Study
LONDON, UK / ACCESS Newswire / November 11, 2025 / A new study in Animals highlights that industrialized animal farming is one of the most powerful - yet persistently neglected - forces driving the climate and biodiversity crises. The analysis, "The Missing Target: Why Industrialized Animal Farming Must Be at the Core of the Climate Agenda," synthesizes evidence from 47 international studies and concludes that reducing livestock production and embracing plant-based food systems is essential for meeting global climate goals.
NanoViricides Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close
SHELTON, CONNECTICUT / ACCESS Newswire / November 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced that it has entered into a securities purchase agreement with a single healthcare institutional investor for the purchase and sale of 3,571,429 shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $1.68 per share in a registered direct offering (the "Offering"). The gross proceeds from the Offering are expected to be approximately $6 million, before deducting placement agent commissions and other offering expenses. In addition, in a concurrent private placement, the Company will issue and sell Series A warrants to purchase up to 3,571,429 shares of common stock (the "Series A Warrants") and Series B warrants to purchase up to 3,571,429 shares of common stock (the "Series B Warrants" and, together with the Series A Warrants, the "Warrants"). The Series A Warrants will have an exercise price of $1.75 per share, will be exercisable after 6 months from date of issuance, and will expire 2 years following the issuance date. The Series B Warrants will have an exercise price of $2.00 per share, will be exercisable after 6 months from date of issuance, and will expire 5.5 years following the issuance date. The exercise price of the Series B Warrants represents approximately a 20% premium to the closing price for the Company's common stock on November 10, 2025. The closing of the Offering is expected to occur on or about November 12, 2025, subject to the satisfaction of customary closing conditions.
'Netflix House' marks streaming giant's first theme park
After years of temporary pop-up events, streaming giant Netflix will make its first foray into the theme park space this week, rivalling entertainment giants Disney and Universal Studios.
Top US court hears case of Rastafarian whose hair was cut in prison
The US Supreme Court on Monday heard the case of a devout Rastafarian who is seeking damages after his knee-length dreadlocks were forcibly shorn while he was in prison in Louisiana.
Chinese 'goddess of wealth' faces jail after huge UK crypto seizure
A Chinese woman facing a long jail term for her role in a multibillion-dollar Bitcoin scam lived in luxury as she evaded the authorities for years, a UK court heard Monday.
Indian capital car blast kills at least eight
A car explosion in the bustling heart of the Indian capital on Monday killed at least eight people and injured another 19, officials said.
US strikes on alleged drug boats kill six more people
US forces have killed six more people in strikes on alleged drug-running boats, Defense Secretary Pete Hegseth said Monday, bringing the campaign's total number of deaths -- which critics describe as illegal executions -- to 76.
Sarkozy released from jail 'nightmare' pending appeal trial
Nicolas Sarkozy on Monday was freed from prison, a 20-day experience the former president called a "nightmare", as a judge ordered his release pending an appeal decision over Libyan funding.
Typhoon Fung-wong floods Philippine towns, leaves 5 dead in its wake
Entire villages lay submerged and scores of towns remained without electricity on Monday as Typhoon Fung-wong left the Philippines after killing at least five people and displacing more than a million.
France's Sarkozy says prison a 'nightmare' as prosecutors seek his release
Nicolas Sarkozy on Monday called his imprisonment a "nightmare" as prosecutors requested the former French president be released from jail pending an appeals trial over Libyan funding.
Guinness maker Diageo picks new CEO after US tariffs cloud
Diageo, the maker of Guinness beer and Smirnoff vodka, announced Monday a new chief executive as it seeks to improve performance hit partly by US President Donald Trump's tariffs.
French court to decide if ex-president Sarkozy can leave jail
A French court is expected to decide on Monday whether to release ex-president Nicolas Sarkozy from jail pending an appeals trial over allegations that he sought Libyan funding.
Japan death row inmate's sister still fighting, even after release
Hideko Hakamada campaigned for almost six decades to get her little brother, the world's longest-serving death row inmate, cleared. But at 92 she refuses to relax, campaigning against capital punishment in Japan and beyond.
Indonesia names late dictator Suharto a national hero
Indonesia added former president Suharto to a list of national heroes during a ceremony on Monday, despite objections from activists and academics over the deceased military dictator's human rights record.
Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025
HILLSIDE, NJ / ACCESS Newswire / November 10, 2025 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2025.
NanoViricides Has Received Approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of the Democratic Republic of Congo
SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today reported that it has received approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of the Democratic Republic of Congo (DRC).
Organto Foods Begins Trading On OTCQX(R) Best Market In The United States
Marks Strategic U.S. Capital Markets Milestone